News

Stay up-to-date about the latest news from the 23andMe Therapeutics Team.

23andMe signs a strategic agreement with Almirall

The agreement gives Almirall the license rights of a bispecific monoclonal antibody that blocks all three isoforms of IL-36 cytokine

Learn More

GSK and 23andMe sign an exclusive agreement to leverage genetic insights for the development of novel medicines

Multi-year collaboration expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programs

Learn More

Pioneer behind 23andMe DNA kits talks company’s next big thing

Anne Wojcicki discusses how 23andMe is becoming a player in medical research for age-old genetic diseases

Learn More

Richard Scheller talks about 23andMe’s approach to drug discovery

Recent Blog Posts

September 21, 2021

Helping to Drive Discovery in 23andMe’s Therapeutics Division

Xin Fang’s interest in science started at the dinner table, listening to her parents talking about what they did each day. Both her mom and dad are plant scientists. Her mom...

The post Helping to Drive Discovery in 23andMe’s Therapeutics Division appeared first on 23andMe Blog.

Read More
September 17, 2021

23andMe Offers Revelations for Adoptee Searching for His Siblings

Adoptee and filmmaker Aaron Harris used 23andMe to help him learn more about himself, and his connections to his birth family.

The post 23andMe Offers Revelations for Adoptee Searching for His Siblings appeared first on 23andMe Blog.

Read More
September 15, 2021

Taking Control for a Healthier Pregnancy 

23andMe released a new 23andMe+ report on gestational diabetes report, which affects an estimated 6 to 9 percent of those expecting. The report looks at a person's ethnicity and more than 6,000 genetic variants associated with developing gestational diabetes mellitus, commonly known as gestational diabetes, during pregnancy.

The post Taking Control for a Healthier Pregnancy  appeared first on 23andMe Blog.

Read More
September 14, 2021

Talking About Rare Disease with Senior Scientist Suyash Shringarpure

23andMe senior scientist in statistical genetics, Suyash Shringarpure, Ph.D. talks about 23andMe's research model and how it offers a surprising opportunity in the study of rare diseases.

The post Talking About Rare Disease with Senior Scientist Suyash Shringarpure appeared first on 23andMe Blog.

Read More